Sumimoto H - Search Results

1

Isolation of a new melanoma antigen, MART-2, containing a mutated epitope recognized by autologous tumor-infiltrating T lymphocytes.

Kawakami Y, Wang X, Shofuda T, Sumimoto H, Tupesis J, Fitzgerald E, Rosenberg S. Kawakami Y, et al. Among authors: sumimoto h. J Immunol. 2001 Feb 15;166(4):2871-7. doi: 10.4049/jimmunol.166.4.2871. J Immunol. 2001. PMID: 11160356

2

Rapid and efficient generation of lentivirally gene-modified dendritic cells from DC progenitors with bone marrow stromal cells.

Sumimoto H, Tsuji T, Miyoshi H, Hagihara M, Takada-Yamazaki R, Okamoto S, Ikeda Y, Takahashi T, Kawakami Y. Sumimoto H, et al. J Immunol Methods. 2002 Dec 20;271(1-2):153-65. doi: 10.1016/s0022-1759(02)00342-3. J Immunol Methods. 2002. PMID: 12445738

3

Inhibition of growth and invasive ability of melanoma by inactivation of mutated BRAF with lentivirus-mediated RNA interference.

Sumimoto H, Miyagishi M, Miyoshi H, Yamagata S, Shimizu A, Taira K, Kawakami Y. Sumimoto H, et al. Oncogene. 2004 Aug 12;23(36):6031-9. doi: 10.1038/sj.onc.1207812. Oncogene. 2004. PMID: 15208655

4

Optimization of an siRNA-expression system with an improved hairpin and its significant suppressive effects in mammalian cells.

Miyagishi M, Sumimoto H, Miyoshi H, Kawakami Y, Taira K. Miyagishi M, et al. Among authors: sumimoto h. J Gene Med. 2004 Jul;6(7):715-23. doi: 10.1002/jgm.556. J Gene Med. 2004. PMID: 15241778

5

Gene therapy for human small-cell lung carcinoma by inactivation of Skp-2 with virally mediated RNA interference.

Sumimoto H, Yamagata S, Shimizu A, Miyoshi H, Mizuguchi H, Hayakawa T, Miyagishi M, Taira K, Kawakami Y. Sumimoto H, et al. Gene Ther. 2005 Jan;12(1):95-100. doi: 10.1038/sj.gt.3302391. Gene Ther. 2005. PMID: 15385954

6

Identification of human tumor antigens and its implications for diagnosis and treatment of cancer.

Kawakami Y, Fujita T, Matsuzaki Y, Sakurai T, Tsukamoto M, Toda M, Sumimoto H. Kawakami Y, et al. Among authors: sumimoto h. Cancer Sci. 2004 Oct;95(10):784-91. doi: 10.1111/j.1349-7006.2004.tb02182.x. Cancer Sci. 2004. PMID: 15504244 Free PMC article. Review.

7

Immunological detection of altered signaling molecules involved in melanoma development.

Kawakami Y, Sumimoto H, Fujita T, Matsuzaki Y. Kawakami Y, et al. Among authors: sumimoto h. Cancer Metastasis Rev. 2005 Jun;24(2):357-66. doi: 10.1007/s10555-005-1583-y. Cancer Metastasis Rev. 2005. PMID: 15986143 Review.

8

Effective inhibition of cell growth and invasion of melanoma by combined suppression of BRAF (V599E) and Skp2 with lentiviral RNAi.

Sumimoto H, Hirata K, Yamagata S, Miyoshi H, Miyagishi M, Taira K, Kawakami Y. Sumimoto H, et al. Int J Cancer. 2006 Jan 15;118(2):472-6. doi: 10.1002/ijc.21286. Int J Cancer. 2006. PMID: 16052531

9

Possible involvement of allogeneic antigens recognised by donor-derived CD4 cytotoxic T cells in selective GVL effects after stem cell transplantation of patients with haematological malignancy.

Matsushita M, Yamazaki R, Ikeda H, Mori T, Sumimoto H, Fujita T, Okamoto S, Ikeda Y, Kawakami Y. Matsushita M, et al. Among authors: sumimoto h. Br J Haematol. 2006 Jan;132(1):56-65. doi: 10.1111/j.1365-2141.2005.05843.x. Br J Haematol. 2006. PMID: 16371020 Free article.

10

The BRAF-MAPK signaling pathway is essential for cancer-immune evasion in human melanoma cells.

Sumimoto H, Imabayashi F, Iwata T, Kawakami Y. Sumimoto H, et al. J Exp Med. 2006 Jul 10;203(7):1651-6. doi: 10.1084/jem.20051848. Epub 2006 Jun 26. J Exp Med. 2006. PMID: 16801397 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

243 results

Search Page

Filters